RRSVX | VSCAX | RRSVX / VSCAX | |
Total Expense Ratio | 0.81 | 1.12 | 72% |
Annual Report Gross Expense Ratio | 34.71 | 1.12 | 3,099% |
Fund Existence | 9 years | 26 years | - |
Gain YTD | -4.334 | 2.680 | -162% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 250000 | 1000 | 25,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.87M | 6.94B | 0% |
Annual Yield % from dividends | 1.12 | 0.35 | 325% |
Returns for 1 year | -5.56 | 1.98 | -281% |
Returns for 3 years | 22.46 | 41.95 | 54% |
Returns for 5 years | 60.11 | 122.98 | 49% |
Returns for 10 years | N/A | 22.74 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
KNPYX | 132.75 | 0.02 | +0.02% |
Kinetics Paradigm Instl | |||
GSRCX | 11.99 | N/A | N/A |
Goldman Sachs Rising Dividend Gr C | |||
LVAVX | 14.03 | -0.02 | -0.14% |
LSV Conservative Value Equity Investor | |||
VTSNX | 148.45 | -0.27 | -0.18% |
Vanguard Total Intl Stock Index I | |||
JFNNX | 65.70 | -0.62 | -0.93% |
Janus Henderson Global Life Sciences N |